Nonpeptide angiotensin II receptor antagonists: potential advantages over ACE inhibitors.

Brooks, D P; DePalma, P D; Fredrickson, T A; Spielman, W S; Ruffolo, R R

Brooks, D P; DePalma, P D; Fredrickson, T A; Spielman, W S; Ruffolo, R R.

Affiliation

Brooks DP; Department of Renal Pharmacology, SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406-0939.

Proc West Pharmacol Soc ; 36: 25-8, 1993.

Article in En | MEDLINE | ID: mdl-8378384

Subject(s)

Acrylates/toxicity; Acute Kidney Injury/chemically induced; Angiotensin II/metabolism; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors/toxicity; Cough/chemically induced; Imidazoles/toxicity; Thiophenes; Acute Kidney Injury/physiopathology; Angiotensin I/pharmacology; Animals; Blood Pressure/drug effects; Captopril/toxicity; Cough/physiopathology; Dogs; Enalapril/toxicity; Female; Glomerular Filtration Rate/drug effects; Male; Renal Circulation/drug effects

Search on Google

Add to My VHL

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Thiophenes / Acrylates / Angiotensin II / Angiotensin-Converting Enzyme Inhibitors / Cough / Acute Kidney Injury / Angiotensin Receptor Antagonists / Imidazoles Limits: Animals Language: En Journal: Proc West Pharmacol Soc Year: 1993 Document type: Article

Search on Google

Add to My VHL

XML

PubMed Links